Is It Too Late To Consider Hims & Hers Health (HIMS) After Recent Share Price Pullback
-
For investors wondering whether Hims & Hers Health still offers good value after its rise as a telehealth brand, or if the easier gains are already behind it, this article walks through what the current price could be implying about the business.
-
The stock last closed at US$31.69, with a 7 day return of an 8.7% decline, a 30 day return of a 14.8% decline, a year to date return of a 5.1% decline, a 1 year return of 22.4%, and a 3 year return that is a very large multiple of its earlier level, alongside a 5 year return of 75.7%.
-
Recent coverage around Hims & Hers Health has focused on its role in online healthcare and consumer telehealth services, which has kept investor attention on how scalable its model might be. This context…
